N-(4-Chloro-3-((3-methyl-2-butenyl)oxy)phenyl)-2-methyl-3-furancarbothioamide (BioDeep_00000837899)

   


代谢物信息卡片


N-(4-Chloro-3-((3-methyl-2-butenyl)oxy)phenyl)-2-methyl-3-furancarbothioamide

化学式: C17H18ClNO2S (335.07467180000003)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=C(C=CO1)C(=S)NC2=CC(=C(C=C2)Cl)OCC=C(C)C
InChI: InChI=1S/C17H18ClNO2S/c1-11(2)6-8-21-16-10-13(4-5-15(16)18)19-17(22)14-7-9-20-12(14)3/h4-7,9-10H,8H2,1-3H3,(H,19,22)

描述信息

C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
C254 - Anti-Infective Agent > C281 - Antiviral Agent

同义名列表

1 个代谢物同义名

N-(4-Chloro-3-((3-methyl-2-butenyl)oxy)phenyl)-2-methyl-3-furancarbothioamide



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Charlene S Dezzutti, Julie Russo, Lin Wang, Kaleab Z Abebe, Jie Li, David R Friend, Ian M McGowan, Lisa C Rohan. Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation. PloS one. 2014; 9(7):e102585. doi: 10.1371/journal.pone.0102585. [PMID: 25025306]
  • Katherine Bunge, Ingrid Macio, Leslie Meyn, Lisa Noguchi, Michael A Parniak, Jill L Schwartz, Bernard Moncla, Sharon Hillier. The safety, persistence, and acceptability of an antiretroviral microbicide candidate UC781. Journal of acquired immune deficiency syndromes (1999). 2012 Aug; 60(4):337-43. doi: 10.1097/qai.0b013e3182575914. [PMID: 22495787]
  • B J Moncla, K Pryke, L C Rohan, H Yang. Testing of viscous anti-HIV microbicides using Lactobacillus. Journal of microbiological methods. 2012 Feb; 88(2):292-6. doi: 10.1016/j.mimet.2011.12.013. [PMID: 22226641]
  • Naser L Rezk. Development and validation of LC-ESI-MS method for sensitive, accurate and rapid determination of UC-781 in New Zealand white rabbit plasma. Talanta. 2011 Sep; 85(4):2074-9. doi: 10.1016/j.talanta.2011.07.037. [PMID: 21872060]
  • Peter A Anton, Terry Saunders, Julie Elliott, Elena Khanukhova, Robert Dennis, Amy Adler, Galen Cortina, Karen Tanner, John Boscardin, William G Cumberland, Ying Zhou, Ana Ventuneac, Alex Carballo-Diéguez, Lorna Rabe, Timothy McCormick, Henry Gabelnick, Christine Mauck, Ian McGowan. First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy. PloS one. 2011; 6(9):e23243. doi: 10.1371/journal.pone.0023243. [PMID: 21969851]
  • Carol Lackman-Smith, Clay Osterling, Katherine Luckenbaugh, Marie Mankowski, Beth Snyder, Gareth Lewis, Jeremy Paull, Albert Profy, Roger G Ptak, Robert W Buckheit, Karen M Watson, James E Cummins, Brigitte E Sanders-Beer. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrobial agents and chemotherapy. 2008 May; 52(5):1768-81. doi: 10.1128/aac.01328-07. [PMID: 18316528]
  • Jill L Schwartz, George Kovalevsky, Jaim-Jou Lai, Susan A Ballagh, Timothy McCormick, Karen Douville, Christine K Mauck, Marianne M Callahan. A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor. Sexually transmitted diseases. 2008 Apr; 35(4):414-9. doi: 10.1097/olq.0b013e318162c4d8. [PMID: 18362865]
  • C Goddeeris, J Coacci, G Van den Mooter. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2007 May; 66(2):173-81. doi: 10.1016/j.ejpb.2006.10.005. [PMID: 17158039]
  • A Robert Neurath, Nathan Strick, Yun-Yao Li. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC infectious diseases. 2006 Oct; 6(?):150. doi: 10.1186/1471-2334-6-150. [PMID: 17042959]
  • Jan Balzarini, Kristel Van Laethem, Sigrid Hatse, Matheus Froeyen, Els Van Damme, Anders Bolmstedt, Willy Peumans, Erik De Clercq, Dominique Schols. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Molecular pharmacology. 2005 May; 67(5):1556-65. doi: 10.1124/mol.104.005082. [PMID: 15718224]
  • Jan Balzarini, Sigrid Hatse, Kurt Vermeire, Katrien Princen, Stefano Aquaro, Carlo-Federico Perno, Erik De Clercq, Herman Egberink, Guy Vanden Mooter, Willy Peumans, Els Van Damme, Dominique Schols. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrobial agents and chemotherapy. 2004 Oct; 48(10):3858-70. doi: 10.1128/aac.48.10.3858-3870.2004. [PMID: 15388446]
  • R W Buckheit, M Hollingshead, S Stinson, V Fliakas-Boltz, L A Pallansch, J Roberson, W Decker, C Elder, S Borgel, C Bonomi, R Shores, T Siford, L Malspeis, J P Bader. Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1. AIDS research and human retroviruses. 1997 Jun; 13(9):789-96. doi: 10.1089/aid.1997.13.789. [PMID: 9171223]
  • J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq, A Karlsson. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. Molecular pharmacology. 1996 Aug; 50(2):394-401. doi: NULL. [PMID: 8700148]